by University of Eastern Finland Schematic illustration depicting miR-466c targeting of murine Vegfa promoter. Credit: PLOS ONE (2022). DOI: 10.1371/journal.pone.0265948 A novel angiogenic microRNA drug can be a new option for the treatment of ischemic cardiovascular disease, according to a new study published in PLOS One by researchers from the University of Eastern Finland together with international collaborators. In...
